AzTrials
AzTrials

ConstipationPhase 2/3NCT02073006

A Study to Evaluate the Effects of a Natural Supplement in Adults With Chronic Functional Constipation

A Phase 2/3 study testing Natural Fibre Supplement in people with Constipation, run by Atlantia Food Clinical Trials at 1 site in Ireland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Constipation is common in the general population, especially in women and in the elderly. Hard stool is a complaint often associated with constipation, which suggests that stool softening would provide a major benefit in the strategy of treatment. Read more about this study

Who is it for?
Ages 18 to 80 yearsHealthy volunteers can take part
Conditions the study is for
Constipation
What is being tested?
Natural Fibre Supplement
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
70 participants
Where
1 siteIreland
Study dates
Feb 2014to Oct 2014
Phase
Phase 2/3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • To be considered eligible for enrolment into the study, subjects must;
  • Be able to give written informed consent,
  • Be between 18 and 80 years of age,
  • Subject has chronic functional constipation according to the Rome III Diagnostic Criteria, where (f) is mandatory.
  • Must include two or more of the following:
  • Straining during at least 25% of defæcations
Show all 13Show fewer
  • Lumpy or hard stools in at least 25% of defæcations
  • Sensation of incomplete evacuation for at least 25% of defæcations
  • Sensation of anorectal obstruction / blockage for at least 25% of defaecations
  • Manual manœuvers to facilitate at least 25% of defæcations (e.g., digital evacuation, support of the pelvic floor)
  • Fewer than 3 defæcations per week ii. Loose stools are rarely present without the use of laxatives iii. Insufficient criteria for irritable bowel syndrome * Criteria fulfilled for the last 3 months, with symptom onset at least 6 months prior to diagnosis
  • Subjects will continue on his/her normal diet,
  • The subject agrees to complete the Patient Diary for two weeks prior to study entry and for the duration of the study.

Who cannot join

  • Subjects will be excluded from the study if they meet any of the below criteria;
  • Are less than 18 and greater than 80 years of age,
  • Females are pregnant, lactating or wish to become pregnant during the study.
  • Are hypersensitive to any of the components of the test product,
  • Have a significant acute or chronic, unstable and untreated disease or any condition which contraindicates, in the investigators judgement, entry to the study,
  • Subject has an obstructive or metabolic aetiology for constipation,
Show all 14Show fewer
  • Subject has a history of laxative abuse (greater than the daily dosage recommended on the label for any laxative),
  • Subject has used a probiotic or prebiotic product or a dietary fibre supplement in the 4 weeks prior to the baseline visit,
  • Subject has a history of drug and/or alcohol abuse at the time of enrolment
  • Having a condition or have taken a medication that the investigator believes would interfere with the objectives of the study, pose a safety risk or confound the interpretation of the study results;
  • Individuals who, in the opinion of the investigator, are considered to be poor attendees or unlikely for any reason to be able to comply with the trial,
  • Subjects may not be receiving treatment involving experimental drugs,
  • If the subject has been in a recent experimental trial, these must have been completed not less than 90 days prior to this study.
  • Have a malignant disease or any concomitant end-stage organ disease

Trial locations and contacts

1 site in 1 country.

Ireland1 site
  • Atlantia Food Clinical Trials, University College Cork

    Cork

Other trials in Ireland

About this study

Official title: A Randomised, Double-blind, Placebo-Controlled, Parallel Study to Evaluate the Effects of Lepicol® in Adults With Chronic, Functional Constipation

Constipation is common in the general population, especially in women and in the elderly. Hard stool is a complaint often associated with constipation, which suggests that stool softening would provide a major benefit in the strategy of treatment.

This investigative fibre product is primarily a soluble dietary fibre with added probiotics and a prebiotic. It is not digested in the small intestine and partly remains undigested by bacteria in the gut. Also, as probiotics are believed to help restore a healthy gut flora, reduce pH, assist with digestion of food and reduce gaseous by-products they may aid the improvement of intestinal motility.

The objective of this study is to assess if this investigative, fibre product effects the number of bowel movements per week and if this in turn impacts quality of life and symptoms of constipation.

Read the detailed description

Constipation is a common condition. Perception of a healthy bowel movement varies widely within and among populations but the Rome III Criteria is a standardised tool that diagnoses functional constipation on the basis of the following symptoms for the last 3 months with symptom onset at least 6 months prior to diagnosis:

  1. Must include two or more of the following:
  • Straining during at least 25% of defecations
  • Lumpy or hard stools in at least 25% of defecations
  • Sensation of incomplete evacuation for at least 25% of defecations
  • Sensation of anorectal obstruction/blockage for at least 25% of defecations
  • Manual manoeuvres to facilitate at least 25% of defecations (e.g., digital evacuation, support of the pelvic floor)
  • Fewer than three defecations per week
  1. Loose stools are rarely present without the use of laxatives
  2. Insufficient criteria for irritable bowel syndrome

Additional to being extremely uncomfortable, untreated constipation can lead to faecal impaction (with resulting faecal incontinence), particularly in elderly and confused people and is believed to be a risk factor for haemorrhoids (piles) and diverticular disease. However even without a medical diagnosis the undesired symptoms can reduce perceived quality of life and successful management may involve a number of factors. Standard treatment consists of disimpaction and the administration of laxatives to achieve a normal bowel habit of passing a soft stool without pain. The daily use of laxatives long term is often advised against as it can make your body dependent on them, causing your bowel to no longer function normally.

Stool softening is a physician's first step in the management of chronic constipation. Psyllium has been shown to soften stools by increasing stool water content, far more than most common dietary fibres. It forms a soft gel which eases the stool along the lower digestive tract ready for evacuation. This bulkier faeces presses on the wall of the intestine, stimulating the muscles to contract and force the contents forward, a process known as 'peristalsis'. If there is insufficient fibre in the diet, the faeces will move more slowly and there will be more time for water to be absorbed from the ingested food into the rest of the body, leaving the faeces smaller and harder, which in turn is more difficult to move. Psyllium has the advantage of being much gentler than some common fibres (such as wheat bran) that can be irritating to a sensitive bowel.

Studies using psyllium in a range of doses of 7g up to 24g a day show positive results in relation to increasing stool frequency and weight, and improving stool consistency, in turn improving associated abdominal pain and discomfort. These results were applicable in both adults and the elderly. Although psyllium works in a much more gentle natural way, in some studies it was seen to be superior to or comparative to commonly used laxatives.

Probiotics had the added advantage of improving stool frequency and consistency and accompanying abdominal pain, most likely by their positive effects on the gut microflora often seen to be imbalanced in those with constipation. These effects were seen in infants, adults and the elderly with no adverse events such inducing loose stools.

Lastly, inulin in a range of doses of 1.5g up to 50g a day was seen to improve not only beneficial bacteria counts but also bowel transit in infants, adults and the elderly and in one study was again seen to be more effective than a common laxative but without the side effects.

This study aims to increase the body of scientific data on psyllium by way of a randomised, placebo-controlled study.

Conditions
Constipation
Being tested
Natural Fibre Supplement
Keywords
Chronic, Functional, Constipation, less than 3 bowel movements per week
Medical subject headings
Constipation, Bronchiolitis Obliterans Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Natural Fibre SupplementDietary supplement

    Also called Lepicol

    Natural Fibre Supplement 2 doses per day for 4 weeks

Study groups in NCT02073006
Study groupRoleWhat they receive
Natural Fibre SupplementActive comparator2 doses per day for 4 weeks
Receives: Dietary Supplement: Natural Fibre Supplement
PlaceboPlacebo comparator2 doses per day for 4 weeks
Receives: Dietary Supplement: Natural Fibre Supplement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of bowel movements per week

    Measured: 4 weeks

Secondary outcomes (4)
  1. Stool consistency, as measured by the Bristol Stool Form Scale

    Measured: 4 weeks

  2. Quality of life as measured by the Quality of Life Questionnaire (PAC-QOL)

    Measured: 4 weeks

  3. Constipation symptoms as measured by PAC-SYM

    Measured: 4 weeks

  4. Laxative use by subjects with functional constipation

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Feb 2014 (estimated)
  2. Study startFeb 2014
  3. Primary completionJul 2014
  4. Study completionOct 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2/3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
70 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02073006
Sponsor's protocol ID
AFCRO-048
Status last verified
Jan 2015
First submitted
25 Feb 2014
Last updated
15 Jan 2015
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Phase 2/3 study testing Natural Fibre Supplement in people with Constipation, run by Atlantia Food Clinical Trials at 1 site in Ireland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 13 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Jan 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Ireland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of bowel movements per week (time frame: 4 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jan 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in